While that is true, you are not including the option of switching to a cheaper insulin. The older insulins (R/N/L) were, the last time I checked, something like $25 per bottle, over the counter.
The problem for you is that you can't do what I do. And maybe the problem for you is also that I can't sell you what I get this way.
So in America you have 'shortages'. I do not. And if you wanted, you could also choose not to have 'shortages'.
I remember the same thing happening when Chloroquine was 'in short supply'. I could always get some. You never could. This is by choice. You live by rules that the universe does not require of you. These are probably for other reasons like perhaps you believe in living by the categorical imperative. But there are predators in this forest who do not believe in that.
¹ Even insulin can come here stably and safe. But drugs for other conditions are easier. And what I'm saying here is not strictly true if you're familiar with the details: it's not actually a generic, etc. etc. The important thing is that it's cheap and available.
If you're looking for a contrasting inelastic market (one with a simpler regulatory landscape), I'd look for other industries with high capital costs, such as semiconductor manufacturing.
To expand slightly (all IM opinion/observation):
a) Often, there isn't a 'market', as there might not be multiple competitive options for each disease.
b) Even in situations where there are (say) two roughy similar treatments for a disease, market forces don't always apply - manufacturers differentiate via other routes and try to avoid price erosion.
c) It's uncertain how often price directly influences prescribing decisions (in the US, or indeed in many countries).